Abnormal blood clotting was one of the first mysterious health effects to emerge in the COVID pandemic, first, as an effect of the natural infection, and later, as a side effect of the COVID jabs. By mid-March 2021, barely four months after the rollout of the COVID injections, 19 European countries plus Thailand1 had suspended… Read More »
Pfizer’s Paxlovid was granted emergency use authorization to treat mild to moderate COVID-19 in December 2021.1 The drug consists of nirmatrelvir tablets — the antiviral component — and ritonavir tablets, which are intended to slow the breakdown of nirmatrelvir.2 What started out as a slow rollout — only 40,000 or fewer prescriptions were written for… Read More »
In a news release quietly published June 29, 2022, the U.S. Department of Health and Human Services announced that it, in partnership with the Department of Defense, agreed to purchase another 105 million doses of Pfizer’s COVID-19 shot — for $ 3.2 billion.1 The contract is intended to supply shots for a coming fall injection… Read More »
Jessica Rose, Ph.D., a research fellow at the Institute for Pure and Applied Knowledge in Israel, has taken a deep-dive into the U.S. Vaccine Adverse Events Reporting System (VAERS), and in this interview she shares the details of what she’s finding. VAERS, despite flaws and drawbacks, is one of the greatest tools we have to… Read More »
Considering the scale of the mass vaccination campaign against COVID-19, if the shots were working as advertised, we’d have vaccine-induced herd immunity already. As of October 28, 2021, 6.94 billion doses of COVID-19 jabs had been administered, equating to 49% of the world population having received at least one dose.1 Add to that the fact… Read More »